BioNTech to Share Vaccine Technology With China

A new German–Chinese vaccine venture is on the horizon. Germany’s BioNtech and a unit of Shanghai Fosun Pharmaceutical are joining forces on the project, according to a company filing on Sunday.

The Chinese drugmaker will give BioNTech $100 million in assets and funding. In return, BioNTech will give the Chinese drugmaker its vaccine manufacturing technology. A plant will also be built in China, where BioNTech will produce its vaccines.

China in Focus Weekly Newsletter
Find out what's really going on in China
By registering for the newsletter, you agree to the Privacy Policy.